Da Hai Xu
Presidente en Beijing Tri Prime Gene Pharmaceutical Co., Ltd. .
Perfil
Da Hai Xu is currently the Chairman-Supervisory Board at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Xu has a Master's in Business Administration from Shanghai Advanced Institute of Finance and an undergraduate degree from Fuyang Normal University.
Cargos activos de Da Hai Xu
| Empresas | Cargo | Inicio |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Presidente | - |
Formación de Da Hai Xu.
| Shanghai Advanced Institute of Finance | Masters Business Admin |
| Fuyang Normal University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
 | Health Technology |
- Bolsa de valores
- Insiders
- Da Hai Xu
